A federal judge found that Mr. Shkreli violated state and federal antitrust laws by trying to maintain a monopoly over a lifesaving drug and must pay back the excess profits.
Source: New York Times
Martin Shkreli Barred From Drug Industry and Must Repay $64.6 Million
Published in Antitrust Laws and Competition Issues, Cote, Denise, Decisions and Verdicts, Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Shkreli, Martin (1983- ) and Vyera Pharmaceuticals LLC
More from Antitrust Laws and Competition IssuesMore posts in Antitrust Laws and Competition Issues »
More from Cote, DeniseMore posts in Cote, Denise »
More from Decisions and VerdictsMore posts in Decisions and Verdicts »
- Disciplinary Charges Dismissed Against Top New York Police Official Jeffrey Maddrey
- New Jersey Ballot Design for Senate Primary Challenged by Federal Judge
- Ex-State Dept. Official Ordered to Bias Training After Anti-Muslim Rant
- Why Is Trump Facing E. Jean Carroll in a Second Defamation Trial?
- Conviction Won’t Be a Financial Death Sentence for Trump Organization
More from Drugs (Pharmaceuticals)More posts in Drugs (Pharmaceuticals) »
More from Prices (Fares, Fees and Rates)More posts in Prices (Fares, Fees and Rates) »
Be First to Comment